Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Urine Testing to Detect Kidney Transplant Rejection
Completed clinical trial evaluating a urine test to detect kidney transplant rejection.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients [Phase 4]
Phase 4 trial comparing bioavailability of mycophenolate mofetil products in stable renal transplant recipients; study terminated with resul…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of a combination immunosuppressive therapy intended to prevent kidney tran…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients [Phase 4]
Phase 4 trial evaluating two sirolimus-based immunosuppressive regimens in elderly kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating injections of regulatory T cells (CD4+CD25+FoxP3+ T cells) to prevent organ reje…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Belatacept to Prevent Organ Rejection in Kidney Transplant Patients [Phase 2]
A Phase 2 clinical trial evaluating belatacept to prevent rejection in kidney transplant patients was terminated, and results were posted in…
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys [Phase 2]
A Phase 2 trial evaluating Campath-1H (alemtuzumab) for preventing kidney transplant rejection has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Rituximab for Pediatric Renal Transplant Rejection [Phase 2, Phase 3]
Phase 2 and Phase 3 trials evaluating rituximab for pediatric kidney transplant rejection have completed. The study investigates rituximab a…
-
CLINICAL_TRIALS trial_result · 2006-05-19Clinical Trial Update: Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients [Phase 4]
A Phase 4 trial comparing two immunosuppressive regimens in de novo kidney transplant recipients has completed.